|
⚲
|
| Keyboard |
| Jill Carroll | |
|---|---|
| Firm | |
| Address | 1001 Page Mill Rd Building 4, Suite 200B Palo Alto, CA 94304 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Airnexis Therapeutics Inc | 021-575781 | Director | 62.0 M of 200.0 M |
||
| Odyssey Therapeutics Inc | 021-565797 | Director | 214.0 M of 214.0 M |
||
| Odyssey Therapeutics Inc | 021-499898 | Director | 117.2 M of 121.1 M |
||
| Avalyn Pharma Inc | 021-494182 | Director | 189.2 M of 189.2 M |
||
| Arcellx Inc | 021-472689 | Director | 100.0 M of 100.0 M |
||
| Odyssey Therapeutics Inc | 021-462964 | Director | 168.0 M of 174.9 M |
||
| Arcellx Inc | 021-436730 | Director | 10.0 M of 10.0 M |
||
| Odyssey Therapeutics Inc | 021-417003 | Director | 91.6 M | ||
| Arcellx Inc | 021-395298 | Director | 120.0 M of 120.0 M |
||
| Pandion Therapeutics HoldCo LLC | 021-364484 | Director | 40.0 M of 80.0 M |
||
| Nkarta Inc | 021-348219 | Director | 43.9 M of 114.6 M |
||
| Arcellx Inc | 021-347172 | Director | 42.8 M of 83.7 M |
||
| Tioma Therapeutics Inc | 021-245292 | Director | 33.2 M of 86.3 M |
||